|
US2015202226A1
|
|
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
EP3110508A1
|
|
Treatment of hereditary angioedema with c1 inhibitor
|
|
AU2014233597A1
|
|
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
|
|
US2015044303A1
|
|
Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them
|
|
EP2822542A1
|
|
Controlled-release solid dosage forms of mesalamine
|
|
AU2013221635A1
|
|
Anti-VLA1 (CD49a) antibody pharmaceutical compositions
|
|
AU2012212194A1
|
|
Selection and treatment of subjects
|
|
AU2011265561A1
|
|
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
EP2068841A2
|
|
Novel formulations of proton pump inhibitors and methods of using these formulations
|
|
US2009092658A1
|
|
Novel formulations of proton pump inhibitors and methods of using these formulations
|
|
WO2007086846A1
|
|
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
CA2609627A1
|
|
Pharmaceutical formulations useful for inhibiting acid secretion
|
|
AU2005331781A1
|
|
Pharmaceutical formulations useful for inhibiting acid secretion
|
|
AU2005204242A1
|
|
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
|
EP1750767A1
|
|
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
CA2561700A1
|
|
Combination of proton pump inhibitor, buffering agent, and prokinetic agent
|
|
AU2005285505A1
|
|
A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
|
|
AU2005213472A1
|
|
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
|
|
CA2543164A1
|
|
Combination of proton pump inhibitor and sleep aid
|
|
MXPA06000524A
|
|
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders.
|
